Stock Ticker

  • Loading stock data...

Ampliphi Biosciences Corp (NYSEMKT:APHB) Gets Affirmative Response From FDA On Phase 2 Development Proposal

Ampliphi Biosciences Corp (NYSEMKT:APHB) has proclaimed the positive feedback they got from the U.S. based Food and Drug Administration (FDA) on their second phase of their development plan. As a result, the company will retain its H.C. Wainwright and Co. LLC to offer the company and its directors on the way forward in reviewing the […]